"Gross working capital of the Company as at 30 June includes the following: Cash and Cash Equivalents – A$57.9 million. Trade Receivables – A$13.4 million. Inventory (at revenue realisation value) – A$37.1 million."
As at 31 December they had payables for $93m, an increase of $13m from 30 June (something they dont highlight in their presentation of course). Gross working capital is a stupid metric to use as it doesnt tell you the full story. As at 31 December the company had negative current assets of $44m.
- Forums
- ASX - By Stock
- TER
- SMR today
SMR today, page-28
-
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TER (ASX) to my watchlist
(20min delay)
|
|||||
Last
21.5¢ |
Change
-0.005(2.27%) |
Mkt cap ! $172.2M |
Open | High | Low | Value | Volume |
22.0¢ | 22.0¢ | 21.5¢ | $64.48K | 295.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 187079 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.0¢ | 531318 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 187079 | 0.215 |
13 | 640081 | 0.210 |
17 | 1052254 | 0.205 |
31 | 1044467 | 0.200 |
11 | 444218 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.220 | 531318 | 11 |
0.225 | 469308 | 11 |
0.230 | 169046 | 8 |
0.235 | 344847 | 6 |
0.240 | 565128 | 8 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
TER (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online